title: Germline mutations in SPI1 and MADD do not contribute to familial chronic lymphocytic leukaemia.
authors.forename: G S
authors.initials: GS
authors.lastname: Sellick
authors.forename: M
authors.initials: M
authors.lastname: Qureshi
authors.forename: S
authors.initials: S
authors.lastname: Fielding
authors.forename: D
authors.initials: D
authors.lastname: Catovsky
authors.forename: R S
authors.initials: RS
authors.lastname: Houlston
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D053418:Death Domain Receptor Signaling Adaptor Proteins; D005192:Family Health; D005260:Female; D018095:Germ-Line Mutation; D020662:Guanine Nucleotide Exchange Factors / Q000235:genetics*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000209:etiology* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D015534:Trans-Activators / Q000235:genetics*; D000099232:Proto-Oncogene Protein Spi-1
chemical_list: D053418:Death Domain Receptor Signaling Adaptor Proteins; D020662:Guanine Nucleotide Exchange Factors; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D000099232:Proto-Oncogene Protein Spi-1; C105852:MADD protein, human